Assignee
BIOMUNEX PHARMACEUTICALS
FR·5 granted patents·3 pending applications·5 citations·filing 2017–2024
Top patents by PatentIndex Score
8 records- 0184US11560437B2Stable multispecific antibodiesBIOMUNEX PHARMACEUTICALS·Filed 2018·Granted Jan 24, 2023·4 cites·14 claims
- 0276US11505616B2Binding molecules to CD38 and PD-L1BIOMUNEX PHARMACEUTICALS·Filed 2017·Granted Nov 22, 2022·1 cites·7 claims
- 0373US2024209118A1Polypeptide linker for preparing multispecific antibodiesBIOMUNEX PHARMACEUTICALS·Filed 2024·Application pending·0 cites
- 0468US12528877B2Binding molecules to CD38 and PD-L1BIOMUNEX PHARMACEUTICALS·Filed 2022·Granted Jan 20, 2026·0 cites·4 claims
- 0557US11958913B2Polypeptide linker for preparing multispecific antibodiesBIOMUNEX PHARMACEUTICALS·Filed 2018·Granted Apr 16, 2024·0 cites·12 claims
- 0657US2025282892A1Bispecific antibodies binding to her-3 and to either her-2 or egfrBIOMUNEX PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0745US2023322952A1Multispecific antibodies that bind both mait and tumor cellsBIOMUNEX PHARMACEUTICALS·Filed 2021·Application pending·0 cites
- 0836US12054550B2Bispecific antibodies targeting EGFR and HER2BIOMUNEX PHARMACEUTICALS·Filed 2017·Granted Aug 6, 2024·0 cites·10 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →